Cargando…
The Role of the PAX8/PPARγ Fusion Oncogene in Thyroid Cancer
Thyroid cancer is uncommon and exhibits relatively low mortality rates. However, a subset of patients experience inexorable growth, metastatic spread, and mortality. Unfortunately, for these patients, there have been few significant advances in treatment during the last 50 years. While substantial a...
Autores principales: | Placzkowski, Kimberly A., Reddi, Honey V., Grebe, Stefan K. G., Eberhardt, Norman L., McIver, Bryan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579323/ https://www.ncbi.nlm.nih.gov/pubmed/18989374 http://dx.doi.org/10.1155/2008/672829 |
Ejemplares similares
-
The Significance of PAX8-PPARγ Expression in Thyroid Cancer and the Application of a PAX8-PPARγ-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer
por: Fan, Tianbing, et al.
Publicado: (2022) -
Underexpression of peroxisome proliferator-activated receptor (PPAR)γ in PAX8/PPARγ-negative thyroid tumours
por: Marques, A R, et al.
Publicado: (2004) -
Rapid methods to create a positive control and identify the PAX8/PPARγ rearrangement in FNA thyroid samples by molecular biology
por: Vuttariello, Emilia, et al.
Publicado: (2018) -
Evaluation and Management of Indeterminate Thyroid Nodules: The Revolution of Risk Stratification Beyond Cytological Diagnosis
por: Valderrabano, Pablo, et al.
Publicado: (2017) -
Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein
por: Nabarro, Stephen, et al.
Publicado: (2005)